Andrew M. Weiss, 10% Owner of Theravance Biopharma TBPH, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $233.4M. The latest trade was on 09/23.

AW

AW

Andrew M. Weiss

Former 10% Owner

Company

Theravance Biopharma TBPH

First filing

26/02/18

Trades

2 trades

Buys / sales

0 / 1

12-month net buying

−$233.4M

Last trade

09/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AP Avadel Pharmaceuticals	Open-market sale	02/13	02/18	11,112,052 sh	$21.00	$233,353,092	−100.0%